يعرض 21 - 40 نتائج من 20,514 نتيجة بحث عن '(( 50 ((((ns decrease) OR (nn decrease))) OR (a decrease)) ) OR ( 5 μ decrease ))', وقت الاستعلام: 0.65s تنقيح النتائج
  1. 21
  2. 22
  3. 23
  4. 24
  5. 25
  6. 26
  7. 27
  8. 28

    FTY720 treatment decreased tumor growth in a xenograft model of hepatoblastoma. حسب Laura L. Stafman (6577184)

    منشور في 2019
    "…<p>(A) HuH6 cells (2.5 x 10<sup>6</sup> cells in 25% Matrigel) were injected subcutaneously into the right flank of 6-week-old female athymic nude mice. …"
  9. 29
  10. 30
  11. 31

    The GluN2B-C456Y mutation decreases recombinant NMDAR currents and alters receptor properties. حسب Wangyong Shin (6793040)

    منشور في 2020
    "…<i>n</i> = 73 oocytes for WT (5.70 ± 0.61 μA) and 59 oocytes for C456Y (0.039 ± 0.004 μA), ***<i>P</i> < 0.001, Mann-Whitney. …"
  12. 32

    FTY720 decreased viability, proliferation, and motility and induced apoptosis in human hepatoblastoma cells. حسب Laura L. Stafman (6577184)

    منشور في 2019
    "…(B) Following 24 hours of treatment with FTY720, the proliferation of HuH6 cells measured using the CellTiter 96 cell proliferation assay was significantly decreased (IC<sub>50</sub> = 6.4 μM, p ≤ 0.05). (C) HuH6 cells were plated and allowed to reach 80% confluence, at which time the media was changed for fresh media (0, 5, or 8 μM FTY720) and a standard scratch wound was made. …"
  13. 33
  14. 34
  15. 35
  16. 36

    GSK343 decreased tumor stemness. حسب Laura V. Bownes (10276762)

    منشور في 2021
    "…(C) COA6 cells were treated with GSK343 (0, 5 μM) for 72 hours. qPCR demonstrated a significant decrease in mRNA abundance of known stemness markers Oct4, Nanog, and Sox2 following GSK343 treatment compared to untreated cells. …"
  17. 37
  18. 38
  19. 39
  20. 40

    Discovery of New Inhibitors of Hepatitis C Virus NS3/4A Protease and Its D168A Mutant حسب Ittipat Meewan (7455041)

    منشور في 2019
    "…Hepatitis C virus (HCV) is a human pathogen with high morbidity. The HCV NS3/4A protease is essential for viral replication and is one of the top three drug targets. …"